NASDAQ:SLGC - Nasdaq - US83444K1051 - Common Stock - Currency: USD
2.1
-0.1 (-4.55%)
The current stock price of SLGC is 2.1 USD. In the past month the price decreased by -22.51%. In the past year, price decreased by -19.54%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
DHR | DANAHER CORP | 28.07 | 151.18B | ||
A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
WAT | WATERS CORP | 31.58 | 22.26B | ||
ICLR | ICON PLC | 14.39 | 16.63B | ||
WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
RVTY | REVVITY INC | 23.23 | 13.85B | ||
AVTR | AVANTOR INC | 17.3 | 11.78B | ||
TEM | TEMPUS AI INC | N/A | 10.72B |
SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company is headquartered in Boulder, Colorado and currently employs 451 full-time employees. The company went IPO on 2021-02-23. The firm has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. The company develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The company offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaScan Certified Sites, SomaSignal Tests and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. Its SOMAmer reagents are proprietary modified aptamers, which are short, synthetic single-stranded DNA (ssDNA) sequences developed to bind specific protein targets with high affinity and specificity across the proteome.
SOMALOGIC INC
C/O Somalogic, Inc., 2945 Wilderness Place
Boulder COLORADO US
Employees: 451
Company Website: https://somalogic.com/
Phone: 13036259000
The current stock price of SLGC is 2.1 USD. The price decreased by -4.55% in the last trading session.
The exchange symbol of SOMALOGIC INC is SLGC and it is listed on the Nasdaq exchange.
SLGC stock is listed on the Nasdaq exchange.
10 analysts have analysed SLGC and the average price target is 4.01 USD. This implies a price increase of 91.05% is expected in the next year compared to the current price of 2.1. Check the SOMALOGIC INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SOMALOGIC INC (SLGC) has a market capitalization of 396.23M USD. This makes SLGC a Small Cap stock.
SOMALOGIC INC (SLGC) currently has 451 employees.
SOMALOGIC INC (SLGC) has a support level at 2.09 and a resistance level at 2.34. Check the full technical report for a detailed analysis of SLGC support and resistance levels.
The Revenue of SOMALOGIC INC (SLGC) is expected to decline by -12.14% in the next year. Check the estimates tab for more information on the SLGC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SLGC does not pay a dividend.
SOMALOGIC INC (SLGC) will report earnings on 2024-03-26, after the market close.
SOMALOGIC INC (SLGC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.69).
ChartMill assigns a technical rating of 1 / 10 to SLGC. When comparing the yearly performance of all stocks, SLGC is a bad performer in the overall market: 78% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to SLGC. No worries on liquidiy or solvency for SLGC as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months SLGC reported a non-GAAP Earnings per Share(EPS) of -0.69. The EPS decreased by -50% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -23.08% | ||
ROE | -26.25% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 80% to SLGC. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -2.43% and a revenue growth -12.14% for SLGC